Global Swine Healthcare Market Segmented by animal diseases, Diagnostic Market, Genetics & By geography - Trends & Forecasts (2017 - 2022)

The global swine healthcare market has been estimated at USD XX billion in 2016 and is projected to reach USD XX billion by the end of 2021, at a CAGR of X% during the forecast period from 2016 to 2021.

Swine disease outbreaks in the US and Europe are starting to reshape the global market. The estimated pig population in 2010 was 966 million, and with countries like China boosting production, this number is set to rise rapidly in the years to come. Although pork consumption in the US has reduced, the rising demand from emerging economies like China more than makes up for the loss in consumption. Even on the supply side, China has created opportunities for smallholder farmers to produce protein sources to meet domestic demand, bolstering swine rearing in the country.

Global Swine Healthcare Market-Market Dynamics

The market is driven by increased pig breeding, domestic and export demand for pork and increasing sow utilization rates.Swine diseases and increase in chicken production are the major factors restraining the market and deflating market pricing for pork production.

The global swine healthcare market has been segmented by diseases: diseases caused by bacteria, mycoplasmas, and spirochetes, domestic viral diseases, parasitic diseases, nutritional deficiencies, toxicoses and poisonings, exotic viral diseases, skin diseases and others; and by swine health products: vaccines, parasiticides, anti-infectives, medicinal feed additives and others.

The global swine healthcare market has also been geographically segmented into Asia-Pacific, Europe, Middle East and North Africa (MENA), North America and Rest of the World, with Asia-Pacific dominating the global market. North America is also an emerging market which has a scope for growth and can potentially dominate the market in the future.

Some of the key players in the market are:

Bayer Animal Health

Boehringer Ingelheim Vetmedica

Ceva Sante Animale



Merial (Animal Health Division of Sanofi)



Key Deliverables in the Study

Market analysis for the swine healthcare market, with region-specific assessments and competition analysis on the global and regional scale.

Market definition along with the identification of key drivers and restraints.

Identification of factors instrumental in changing the market scenario, rising prospective opportunities, and identification of key companies that can influence this market on a global and regional scale.

Extensively researched competitive landscape section with profiles of major companies along with their market share.

Identification and analysis of the macro and micro factors that affect the swine healthcare market on both global and regional scale.

A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.

A wide-ranging knowledge and insights about the major players in this industry and the key strategies adopted by them to sustain and grow in the studied market.

Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped.

1. Introduction

1.1 Study Deliverables

1.2 Market Definition

1.3 Sizing Units

1.4 Base Currency

1.5 Review and Forecast Period Years

1.6 General Study Assumptions

2. Research Methodology

2.1 Introduction

2.2 Analysis Methodology

2.3 Econometric Forecast Model

2.4 Research Assumptions

3. Executive Summary

4. Key Inferences

5. Market Characterization

5.1 Current Market Scenario

5.2 Market Overview

5.3 Drivers, Restraints, Opportunities, and Challenges (DROC) Analysis

5.3.1 Market Drivers Increased Pig Breeding Domestic Demand for Pork Export Demand for Pork

5.3.2 Market Restraints Swine Diseases

5.3.3 Market Opportunities Increasing Sow Utilization Rate

5.3.4 Market Challenges Increase in Chicken Production

5.4 Swine Healthcare Market Segmentation

5.4.1 By Diseases Diseases Caused by Bacteria, Mycoplasmas, and Spirochetes Domestic Viral Diseases Parasitic Diseases Nutritional Deficiencies Toxicoses and Poisonings Exotic Viral Diseases Skin Diseases Others

5.4.2 By Swine Healthcare Products Vaccines Parasiticides Anti-infectives Medicinal Feed Additives Others

5.4.3 By Geography Asia-Pacific Europe Middle East & North Africa (MENA) North America Rest of the World

6. Industry Analysis

6.1 Key Trends and Developments

6.2 Investment Analysis

6.3 PorterFive Forces

6.3.1 Bargaining Power of Suppliers

6.3.2 Bargaining Power of Consumers

6.3.3 Threat of New Entrants

6.3.4 Threat of Substitute Products and Services

6.3.5 Competitive Rivalry within the Industry

7. Competitive Landscape

7.1 Key Market Players

7.1.1 Zoetis Zoetis - Business Overview Zoetis - Product and Services Portfolio Zoetis - Deals Landscape Zoetis - SWOT Analysis

7.1.2 Merck

7.1.3 Merial

7.1.4 Elanco

7.1.5 Bayer Animal Health

7.1.6 Boehringer Ingelheim Vetmedica

7.1.7 Novartis Animal Health

7.1.8 Virbac

7.1.9 Ceva Sante Animale

7.1.10 Vetoquinol

7.1.11 Others

7.2 Merger and Acquisition Analysis

7.3 New Product Launches

7.4 Agreements, Collaborations & Partnerships

8. Analyst Outlook for Investment Opportunities

9. Future Outlook of the Market

Content are not available

Choose License Type